Browsing by Author Lam, EWF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 16 of 16
TitleAuthor(s)Issue DateViews
 
A Novel Splice Variant to NCOR2 as Biomarker for Tamoxifen Resistant Breast Cancer
Proceeding/Conference:WIN 2017 Symposium
Ellis, IMan, PSLee, TKWTsoi, HWong, LSLuk, MYRakha, EALam, EWFGreen, ARCheung, KLCheung, KLKhoo, US
2017
63
 
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2
Journal:Cancers
Leung, MHTsoi, HGong, CMan, EPSZona, SYao, SLam, EWFKhoo, US
2020
31
 
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer
Journal:Clinical Cancer Research
Gong, CMan, PSTsoi, HLee, TKWLee, PMa, STWong, LSLuk, MYRakha, EAGreen, AREllis, IOLam, EWFCheung, KLKhoo, US
2018
78
 
Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer
Journal:PLoS ONE
Chen, JGomes, ARMonteiro, LJWong, SYWu, LHNg, TTKaradedou, CTMillour, JIp, YCCheung, YNSunters, AChan, KYKLam, EWFKhoo, US
2010
212
 
Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer
Journal:Oncogenesis
de Moraes, GNKhongkow, PGong, CYao, SGomes, ARJi, ZKandola, NDelbue, DMan, EPSKhoo, USSharrocks, ADLam, EWF
2015
75
 
The forkhead box M1 protein regulates the transcription of the estrogen receptor α in breast cancer cells
Journal:Journal of Biological Chemistry
Madureira, PAVarshochi, RConstantinidou, DFrancis, RECoombes, RCYao, KMLam, EWF
2006
175
 
Forkhead transcription factor FOXO3a increases Akt activity in breast cancer cell lines through a feed-back mechanism
Proceeding/Conference:HKICC / RCC 2009
Chen, JChan, YKWu, LHIp, YCLam, EWFKhoo, US
2009
140
 
FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression
Journal:Journal of Biological Chemistry
Li, SKMSmith, DKLeung, WYCheung, AMSLam, EWFDimri, GPYao, KM
2008
138
 
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
Journal:Oncogene
Karadedou, CTGomes, ARChen, JPetkovic, MHo, KKZwolinska, AKFeltes, AWong, SYChan, KYKCheung, YNTsang, JWHBrosens, JJKhoo, USLam, EWF
2012
189
 
iASPP and chemoresistance in ovarian cancers: Effects on paclitaxel-mediated mitotic catastrophe
Journal:Clinical Cancer Research
Jiang, LSiu, MKYWong, OGWTam, KFLu, XLam, EWFNgan, HYSLe, XFWong, ESYMonteiro, LJChan, HYCheung, ANY
2011
185
 
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers
Journal:Molecular Cancer
Jiang, LSiu, MKYWong, OGWTam, KFLam, EWFNgan, HYSLe, XFWong, ESYChan, HYCheung, ANY
2010
130
 
Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer
Journal:Oncogene
Gong, CTsoi, HMok, KCCheung, JMan, EPSFujino, KWong, ALam, EWFKhoo, US
2020
31
 
Role of FOXM1 in ovarian carcinogenesis
Proceeding/Conference:Clinical Cancer Research
Zhao, FSiu, KYWong, GWWong, ESYJiang, LLTam, KFNgan, HYSLe, XFLam, EWFCheung, ANY
2013
23
 
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
Journal:Oncogene
Siu, MKYWong, ESYKong, DSHChan, HYJiang, LWong, OGWLam, EWFChan, KKLNgan, HYSLe, XFCheung, AN
2013
79
 
The role of BQ323636.1, a novel splice variant of NCOR2, in modulation of oxidative stress in breast cancer
Proceeding/Conference:AACR Advances in Breast Cancer Research Special Conference, Hollywood, California
Leung, MHTsoi, HMan, EPSLam, EWFKhoo, US
2017
42
 
Translational regulation by eIF4E and its contribution to tamoxifen resistance in breast cancer
Proceeding/Conference:Cancer Research
Gong, CMok, KCCheung, YNMan, PSLam, EWFKhoo, US
2016
55
Showing results 1 to 16 of 16